The Universal Faith, Corona and HIV

The Universal Faith fulfills the commandment Love your Neighbor without distinction of their race, creed or color. The rich are loved equally with the poor. The mentally ill are loved with the healthy emotional minded. The Universal Faith receives in love the gay community.

The whole world has gone into quarantine when the Wuhan China coronavirus was carried by people to other nations in the world. Corona is very contagious and easily is transferred from one person to other. One Corona infected person in a group gathering can infect the whole group. The experts on viral diseases are learning more every day about Corona virus called Covid-19 because it is new appearing in 2019.  People who contact Corona the first few days may not feel any symptoms and are carriers of the virus. Symptoms come after the first few days usually fever. Quarantine is encouraged before the symptoms occur through being in contact without two meters and a mask and glove with infected people.  Infected people are tracked to know where they were to identify other people in contact with them to enter quarantine.

Theratechnologies Bonds, Short Term, High Yield, Fixed Income Investment, Yielding 8% YTM

This week, Durig Capital looks to a Canadian issuer, a specialty pharmaceutical company that is successfully treating long-term HIV patients with its unique medicines so that patients have the opportunity to have a better quality of life. Theratechnologies (TSX:TH) has two landmark drugs, Trogarzo™ and EGRIFTA™ specifically developed to help HIV patients. The company has reported its second quarter results (for the three months ending May 31, 2019) and continues to see outstanding growth over its product lines.

Large-Scale HIV Vaccine Trial Launch Date Confirmed

A team of researchers said Monday that “no later than 2023” they will circulate the first vaccine against Human Immunodeficiency Virus (HIV), which will stop “at least 65%” the spread of the pandemic. They confirmed it in the framework of the 10th World Scientific Conference on HIV in Mexico. A human study will be carried out, involving 3,800 people and is estimated to begin in the coming months in the United States.